Showing results (41-50 of 401) with videos related to
Sort By:
Pageof 41
The American Journal of Clinical Nutrition|September 11, 2015
Best (but oft forgotten) practices: testing for treatment effects in randomized trials by separate analyses of changes from baseline in each group is a misleading approachJ Martin Bland, Douglas G AltmanTrials|December 24, 2011
Comparisons against baseline within randomised groups are often used and can be highly misleadingJ Martin Bland, Douglas G AltmanStatistics in Medicine|November 30, 2018
Statistical methodology for constructing gestational age-related charts using cross-sectional and longitudinal data: The INTERGROWTH-21st project as a case studyEric O Ohuma, Douglas G Altman, Medicina Clinica|February 9, 2006
[Diagnostic (STARD) and prognostic (REMARK) studies]Douglas G Altman, Patrick Mm Bossuyt, , et al.European Journal of Cancer (Oxford, England : 1990)|November 20, 2012
Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal)Gary S Collins, Douglas G AltmanJournal of Clinical Epidemiology|February 19, 2003
Developing a prognostic model in the presence of missing data: an ovarian cancer case studyTaane G Clark, Douglas G AltmanLancet (London, England)|March 30, 2005
Epidemiology and reporting of randomised trials published in PubMed journalsAn-Wen Chan, Douglas G AltmanBMJ (Clinical Research Ed.)|February 1, 2005
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authorsAn-Wen Chan, Douglas G AltmanPrenatal Diagnosis|November 25, 2003
Charts of fetal size: kidney and renal pelvis measurementsLyn S Chitty, Douglas G AltmanNature Clinical Practice. Oncology|November 3, 2005
Primer: an evidence-based approach to prognostic markersDouglas G Altman, Richard D RileyPageof 41